California SB1309 requires health insurance policies to cover followup lung cancer screening and diagnostic services without cost sharing.
California SB1309 mandates that health insurance policies issued, amended, or renewed after January 1, 2027, cover followup screening or diagnostic services for lung cancer recommended by a health care provider. This coverage must not include copayment, coinsurance, deductible, or other cost sharing. The bill defines followup screening or diagnostic services for lung cancer as those provided after an initial abnormal or indeterminate test result, including scans, tissue sampling, biopsy, bronchoscopy, pathology, and surgical consultation.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.